Cost of Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infection Management in Young Children at the Regional and Global Level: A Systematic Review and Meta-Analysis

Abstract

This is the first systematic review and meta-analysis summarizing the current evidence related to the cost of RSV disease among children below 5 years of age. It demonstrates that the economic burden associated with RSV disease is substantial. All data variables in the spreadsheet are documented in the publication, either in the main test or supplementary material.